Results
1 -
2 of
2SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo, Cancer Chemotherapy and Pharmacology The Aurora kinase inhibitors in cancer research and therapy, Journal of Cancer Research and Clinical Oncology